Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

Eosinophils are found in high concentrations in tissues of the gastrointestinal tract, including the colon and rectum. They, ...

Antibiotic treatment during an influenza infection actually impaired the body’s efforts to clear bacteria rather than helping the body heal.

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary disease (COPD), according to a study published online Nov. 27 in The ...

Benralizumab targets a type of white blood cell - called an eosinophil - that can cause inflammation and damage in the lungs. Eosinophils are implicated in about half of asthma attacks and a third ...

A recent novel study published in the New England Journal of Medicine found that Depemokimab can reduce asthma exacerbations ...

This investigational trial will evaluate the effects of three dose levels of oral dexpramipexole for 12 weeks on peripheral blood eosinophil count, lung function, and asthma control. Additionally ...